title: Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls.
authors.affiliation: Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Juul.vandenReek@Radboudumc.nl.
authors.forename: Juul M P A
authors.initials: JMPA
authors.lastname: van den Reek
authors.affiliation: Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Wietske
authors.initials: W
authors.lastname: Kievit
authors.affiliation: Department of Dermatology, Bispebjerg Hospital, Bispebjerg, Denmark.
authors.forename: Robert
authors.initials: R
authors.lastname: Gniadecki
authors.affiliation: Department for Health Evidence, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Jelle J
authors.initials: JJ
authors.lastname: Goeman
authors.affiliation: Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Zweegers
authors.affiliation: Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Peter C M
authors.initials: PCM
authors.lastname: van de Kerkhof
authors.affiliation: Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Marieke M B
authors.initials: MMB
authors.lastname: Seyger
authors.affiliation: Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.
authors.forename: Elke M G J
authors.initials: EMGJ
authors.lastname: de Jong
mesh_terms: D001688:Biological Products / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000494:pharmacology; D003880:Dermatology / Q000592:standards / Q000639:trends; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D020714:Maximum Tolerated Dose; D008545:Melanoma / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D009426:Netherlands; D061214:Patient Safety; D016016:Proportional Hazards Models; D011565:Psoriasis / Q000188:drug therapy; D018570:Risk Assessment; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D016019:Survival Analysis
chemical_list: D001688:Biological Products; D003879:Dermatologic Agents